J. M. Herbert

1.1k total citations
24 papers, 881 citations indexed

About

J. M. Herbert is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, J. M. Herbert has authored 24 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cell Biology. Recurrent topics in J. M. Herbert's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Platelet Disorders and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). J. M. Herbert is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Platelet Disorders and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). J. M. Herbert collaborates with scholars based in France, Switzerland and United States. J. M. Herbert's co-authors include A. Bernat, J C Lormeau, Pierre Savi, Jean-P. Hérault, Maurice Petitou, R.G.M. van Amsterdam, D.G. Meuleman, Peter Hoffmann, Philip Janiak and Jean‐Pierre Bidouard and has published in prestigious journals such as Blood, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

J. M. Herbert

23 papers receiving 829 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
J. M. Herbert 386 323 304 284 154 24 881
Emese Tóth-Zsámboki 255 0.7× 37 0.1× 57 0.2× 194 0.7× 35 0.2× 21 586
K. Tayama 153 0.4× 26 0.1× 75 0.2× 36 0.1× 25 0.2× 27 581
T Kondo 130 0.3× 73 0.2× 42 0.1× 101 0.4× 18 0.1× 37 381
Kiyoko Matsui 92 0.2× 11 0.0× 73 0.2× 44 0.2× 21 0.1× 5 425
Dongzhu Xu 591 1.5× 20 0.1× 62 0.2× 11 0.0× 19 0.1× 40 791
Laura Agnoletti 261 0.7× 9 0.0× 57 0.2× 15 0.1× 41 0.3× 17 700
Nancy Schanze 52 0.1× 15 0.0× 40 0.1× 24 0.1× 14 0.1× 22 398
Haruo Araki 280 0.7× 5 0.0× 85 0.3× 19 0.1× 33 0.2× 36 555
Filippo Molica 96 0.2× 7 0.0× 53 0.2× 15 0.1× 50 0.3× 30 497
Jing-Cheng Li 89 0.2× 7 0.0× 93 0.3× 21 0.1× 30 0.2× 27 634

Countries citing papers authored by J. M. Herbert

Since Specialization
Citations

This map shows the geographic impact of J. M. Herbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Herbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Herbert more than expected).

Fields of papers citing papers by J. M. Herbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Herbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Herbert. The network helps show where J. M. Herbert may publish in the future.

Co-authorship network of co-authors of J. M. Herbert

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Herbert. A scholar is included among the top collaborators of J. M. Herbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Herbert. J. M. Herbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poirier, Bruno, Jean‐Pierre Bidouard, Bart Staels, et al.. (2004). The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obesity and Metabolism. 7(1). 65–72. 165 indexed citations
2.
Roccon, Alain, G Rizzoli, P. Guiraudou, et al.. (2003). 301 SSR149744, a new antiarrhythmic drug, prevents experimental induced atrial fibrillation. European Journal of Heart Failure Supplements. 2(1). 53–54. 2 indexed citations
3.
Janiak, Philip, Pierre Lainée, Charles‐Édouard Luyt, et al.. (2002). Serotonin receptor blockade improves distal perfusion after lower limb ischemia in the fatty Zucker rat. Cardiovascular Research. 56(2). 293–302. 18 indexed citations
4.
Hérault, Jean-P., Françoise Bono, Pierre‐Alexandre Driguez, et al.. (2002). The Structure of Synthetic Oligosaccharides in Relation to Factor IXa Inhibition. Thrombosis and Haemostasis. 88(9). 432–435. 7 indexed citations
5.
Savi, Pierre, et al.. (2001). Studies on the Binding of 3H-SR121566, an Inhibitor of Gp IIb-IIIa Activation. Thrombosis and Haemostasis. 85(4). 702–709. 4 indexed citations
6.
Hérault, Jean-P., et al.. (1999). Effect of Clopidogrel on Thrombin Generation in Platelet-Rich Plasma in the Rat. Thrombosis and Haemostasis. 81(6). 957–960. 45 indexed citations
7.
Hoffmann, Peter, A. Bernat, Pierre Savi, & J. M. Herbert. (1998). Prevention of Thrombosis and Enhancement of Thrombolysis in Rabbits by SR 121787, a Glycoprotein II/III Antagonist. Journal of Pharmacology and Experimental Therapeutics. 286(2). 670–675. 5 indexed citations
8.
Hérault, Jean-P., et al.. (1998). Effect of SR121566A, a Potent GP IIb-IIIa Antagonist on Platelet-mediated Thrombin Generation In Vitro and In Vivo. Thrombosis and Haemostasis. 79(2). 383–388. 38 indexed citations
9.
Herbert, J. M., Jean-P. Hérault, A. Bernat, et al.. (1998). Biochemical and Pharmacological Properties of SANORG 34006, a Potent and Long-Acting Synthetic Pentasaccharide. Blood. 91(11). 4197–4205. 5 indexed citations
10.
Hoffmann, Peter, et al.. (1997). THE SYNTHETIC PENTASACCHARIDE SR 90107A/ORG 31540 DOES NOT RELEASE LIPASE ACTIVITY INTO THE PLASMA. Thrombosis Research. 86(4). 325–332. 3 indexed citations
11.
Hoffmann, Peter, A. Bernat, Pierre Savi, & J. M. Herbert. (1997). Antiplatelet and Antithrombotic Efficacy of SR 121787, a Nonpeptide Orally Active GP IIb/IIIa Antagonist, in Rabbits: Comparison with Clopidogrel and Aspirin. Journal of Cardiovascular Pharmacology. 30(3). 360–366. 17 indexed citations
12.
13.
Amiral, Jean, J C Lormeau, Anne Marfaing‐Koka, et al.. (1997). Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagulation & Fibrinolysis. 8(2). 114–117. 92 indexed citations
14.
Herbert, J. M., Maurice Petitou, J C Lormeau, et al.. (1997). SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent. Cardiovascular Drug Reviews. 15(1). 1–26. 76 indexed citations
15.
Hérault, J P, et al.. (1997). Comparative Effects of Two Direct and Indirect Factor Xa Inhibitors on Free and Clot-Bound Prothrombinase. Journal of Pharmacology and Experimental Therapeutics. 283(1). 16–22. 57 indexed citations
16.
Savi, Pierre, et al.. (1996). cAMP is not an important messenger for ADP-induced platelet aggregation. Blood Coagulation & Fibrinolysis. 7(2). 249–252. 46 indexed citations
17.
Savi, Pierre, Marie-Claude Laplace, & J. M. Herbert. (1994). Evidence for the existence of two different ADP-binding sites on rat platelets. Thrombosis Research. 76(2). 157–169. 35 indexed citations
18.
Klein-Soyer, C, Jean‐Pierre Cazenave, J. M. Herbert, & Jean‐Pierre Maffrand. (1994). SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors. Journal of Cellular Physiology. 160(2). 316–322. 15 indexed citations
19.
Bârzu, Tereza, Alexis Desmoulière, J. M. Herbert, et al.. (1992). O-Acylated heparin derivatives with low anticoagulant activity decrease proliferation and increase α-smooth muscle actin expression in cultured arterial smooth muscle cells. European Journal of Pharmacology. 219(2). 225–233. 16 indexed citations
20.
Herbert, J. M., et al.. (1988). Activity of pentosan polysulphate and derived compounds on vascular endothelial cell proliferation and migration induced by acidic and basic FGF in vitro. Biochemical Pharmacology. 37(22). 4281–4288. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emese Tóth-Zsámboki Breakdown of academic impact, for papers by K. Tayama Breakdown of academic impact, for papers by T Kondo Breakdown of academic impact, for papers by Kiyoko Matsui Breakdown of academic impact, for papers by Dongzhu Xu Breakdown of academic impact, for papers by Laura Agnoletti Breakdown of academic impact, for papers by Nancy Schanze Breakdown of academic impact, for papers by Haruo Araki Breakdown of academic impact, for papers by Filippo Molica Breakdown of academic impact, for papers by Jing-Cheng Li
Rankless by CCL
2026